Related Experiment Videos
Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol
1Department of Laboratory Medicine, Municipal Ho-Pin Hospital, Taipei, Taiwan, R.O.C.
Clinical Chemistry
|June 1, 1997
Summary
Two homogeneous assays for high-density lipoprotein cholesterol (HDL-C) were evaluated. The polyethylene glycol-modified enzymes/alpha-cyclodextrin sulfate (PEGME) assay demonstrated superior accuracy and specificity for routine HDL-C testing compared to the polyanion-polymer/detergent (PPD) assay.
Area of Science:
- Clinical Chemistry
- Biochemistry
- Analytical Chemistry
Background:
- Accurate quantification of high-density lipoprotein cholesterol (HDL-C) is crucial for cardiovascular risk assessment.
- Traditional methods like phosphotungstic acid (PTA)/MgCl2 precipitation are time-consuming and can be subject to interference.
- Development of precise and specific homogeneous HDL-C assays is essential for routine clinical laboratory testing.
Purpose of the Study:
- To evaluate and compare the performance of two novel homogeneous HDL-C assays.
- To assess their accuracy, precision, and specificity against a standard PTA/MgCl2 method.
- To determine the suitability of these homogeneous assays for routine clinical use.
Main Methods:
- Two homogeneous HDL-C assays, polyethylene glycol-modified enzymes/alpha-cyclodextrin sulfate (PEGME) and polyanion-polymer/detergent (PPD), were tested.
- Assay performance was evaluated by comparing results with the phosphotungstic acid (PTA)/MgCl2 precipitation method using 152 patient samples.
- Interference studies were conducted using varying concentrations of triglycerides, bilirubin, and hemoglobin.
Main Results:
- Both homogeneous assays exhibited high precision, with within-run coefficients of variation (CV) < 1.20% and between-run CV < 4.07%.
- Strong correlations were observed between homogeneous assays and the PTA/MgCl2 method (r = 0.987 for PEGME, r = 0.984 for PPD).
- The PEGME assay showed better specificity, with less interference from LDL-C, bilirubin, and hemoglobin compared to the PPD assay, which was markedly affected by LDL-C and bilirubin.
Conclusions:
- The PEGME homogeneous HDL-C assay is accurate, precise, and specific, making it suitable for routine clinical laboratory testing.
- The PPD homogeneous HDL-C assay demonstrated significant interference from LDL-C and bilirubin, rendering it less reliable for routine use.
- Homogeneous assays offer a viable alternative to traditional methods for HDL-C quantification, with PEGME being the preferred choice based on this evaluation.